Topic starter
25/06/2026 12:16 am
TL;DR: Health Canada’s pre-market medical device cybersecurity guidance pushes manufacturers to secure device connections, encrypt data, and build access controls and testing into development before products reach the market, according to DigiCert. The practical shift is that device trust now depends on lifecycle governance, not post-deployment patching.
Editorial analysis by NHI Mgmt Group, based on content published by DigiCert: “Health Canada Guidance for Medical Device Cybersecurity is a Welcome Development”.
Key questions
Q: How should manufacturers secure connected medical devices before release?
A: Manufacturers should treat device trust as a design requirement, not a post-launch fix.
Q: Why do connected medical devices create identity security risk for hospitals?
A: Because they combine long lifetimes, network connectivity, and clinical dependencies, which makes trust failures hard to see and expensive to contain.
Q: What breaks when device access controls are not built into product design?
A: When access controls are deferred, configuration changes and privilege grants become easier to abuse once the device is deployed.
Practitioner guidance
- Define device identity before release Assign each connected medical device a verifiable cryptographic identity and document how it will authenticate to approved back-end systems, including EHR and cloud services.
- Build certificate lifecycle into product governance Track issuance, renewal, revocation, and replacement of device certificates as part of the manufacturer’s security lifecycle, not as an afterthought for operations.
- Constrain configuration and privilege paths Limit who can change device settings, approve integrations, or grant elevated access, and test those boundaries during verification and validation.
Bottom line: Health Canada’s guidance moves connected medical devices into a design-time trust model where authentication, encryption, and access control must be proven before release.
Explore further
View Full Forum → | NHI Foundation Course → | Our Services → | Read the full analysis →
25/06/2026 9:08 am
Pre-market device trust is now an identity governance problem, not just a product security issue. Health Canada’s guidance pushes manufacturers to prove that devices can authenticate, encrypt, and resist tampering before they reach the market. That moves the control point upstream into design, verification, and lifecycle governance. For practitioners, the important shift is that device identity must be treated like any other governed identity surface, with explicit trust boundaries before release.
A question worth separating out:
Q: Should healthcare teams rely on post-deployment patching for device security?
A: No. For connected medical devices, the core trust decisions need to be established before release and then maintained through lifecycle monitoring. Post-deployment patching cannot substitute for authenticated connections, certificate governance, or privilege boundaries that were never designed into the product.
👉 Read our full editorial: Health Canada medical device cybersecurity guidance raises PKI stakes